Copyright Reports & Markets. All rights reserved.

Global Injectable Anticoagulants Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Injectable Anticoagulants by Type
    • 1.3.1 Overview: Global Injectable Anticoagulants Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Injectable Anticoagulants Consumption Value Market Share by Type in 2023
    • 1.3.3 LMWH
    • 1.3.4 Unfractionated Heparin
    • 1.3.5 Fibrinolytics
    • 1.3.6 Others
  • 1.4 Global Injectable Anticoagulants Market by Application
    • 1.4.1 Overview: Global Injectable Anticoagulants Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 VTE
    • 1.4.3 ACS/MI
    • 1.4.4 AF
    • 1.4.5 Others
  • 1.5 Global Injectable Anticoagulants Market Size & Forecast
  • 1.6 Global Injectable Anticoagulants Market Size and Forecast by Region
    • 1.6.1 Global Injectable Anticoagulants Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Injectable Anticoagulants Market Size by Region, (2019-2030)
    • 1.6.3 North America Injectable Anticoagulants Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Injectable Anticoagulants Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Injectable Anticoagulants Market Size and Prospect (2019-2030)
    • 1.6.6 South America Injectable Anticoagulants Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Injectable Anticoagulants Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Injectable Anticoagulants Product and Solutions
    • 2.1.4 Sanofi Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Sanofi Recent Developments and Future Plans
  • 2.2 Genentech (Roche)
    • 2.2.1 Genentech (Roche) Details
    • 2.2.2 Genentech (Roche) Major Business
    • 2.2.3 Genentech (Roche) Injectable Anticoagulants Product and Solutions
    • 2.2.4 Genentech (Roche) Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Genentech (Roche) Recent Developments and Future Plans
  • 2.3 Boehringer Ingelheim
    • 2.3.1 Boehringer Ingelheim Details
    • 2.3.2 Boehringer Ingelheim Major Business
    • 2.3.3 Boehringer Ingelheim Injectable Anticoagulants Product and Solutions
    • 2.3.4 Boehringer Ingelheim Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.4 Aspen
    • 2.4.1 Aspen Details
    • 2.4.2 Aspen Major Business
    • 2.4.3 Aspen Injectable Anticoagulants Product and Solutions
    • 2.4.4 Aspen Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Aspen Recent Developments and Future Plans
  • 2.5 Pfizer
    • 2.5.1 Pfizer Details
    • 2.5.2 Pfizer Major Business
    • 2.5.3 Pfizer Injectable Anticoagulants Product and Solutions
    • 2.5.4 Pfizer Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Pfizer Recent Developments and Future Plans
  • 2.6 Hepalink
    • 2.6.1 Hepalink Details
    • 2.6.2 Hepalink Major Business
    • 2.6.3 Hepalink Injectable Anticoagulants Product and Solutions
    • 2.6.4 Hepalink Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Hepalink Recent Developments and Future Plans
  • 2.7 King-friend
    • 2.7.1 King-friend Details
    • 2.7.2 King-friend Major Business
    • 2.7.3 King-friend Injectable Anticoagulants Product and Solutions
    • 2.7.4 King-friend Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 King-friend Recent Developments and Future Plans
  • 2.8 CSBIO
    • 2.8.1 CSBIO Details
    • 2.8.2 CSBIO Major Business
    • 2.8.3 CSBIO Injectable Anticoagulants Product and Solutions
    • 2.8.4 CSBIO Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 CSBIO Recent Developments and Future Plans
  • 2.9 Amphastar Pharmaceuticals
    • 2.9.1 Amphastar Pharmaceuticals Details
    • 2.9.2 Amphastar Pharmaceuticals Major Business
    • 2.9.3 Amphastar Pharmaceuticals Injectable Anticoagulants Product and Solutions
    • 2.9.4 Amphastar Pharmaceuticals Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Amphastar Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Injectable Anticoagulants Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Injectable Anticoagulants by Company Revenue
    • 3.2.2 Top 3 Injectable Anticoagulants Players Market Share in 2023
    • 3.2.3 Top 6 Injectable Anticoagulants Players Market Share in 2023
  • 3.3 Injectable Anticoagulants Market: Overall Company Footprint Analysis
    • 3.3.1 Injectable Anticoagulants Market: Region Footprint
    • 3.3.2 Injectable Anticoagulants Market: Company Product Type Footprint
    • 3.3.3 Injectable Anticoagulants Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Injectable Anticoagulants Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Injectable Anticoagulants Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Injectable Anticoagulants Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Injectable Anticoagulants Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Injectable Anticoagulants Consumption Value by Type (2019-2030)
  • 6.2 North America Injectable Anticoagulants Market Size by Application (2019-2030)
  • 6.3 North America Injectable Anticoagulants Market Size by Country
    • 6.3.1 North America Injectable Anticoagulants Consumption Value by Country (2019-2030)
    • 6.3.2 United States Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Injectable Anticoagulants Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Injectable Anticoagulants Consumption Value by Type (2019-2030)
  • 7.2 Europe Injectable Anticoagulants Consumption Value by Application (2019-2030)
  • 7.3 Europe Injectable Anticoagulants Market Size by Country
    • 7.3.1 Europe Injectable Anticoagulants Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 7.3.3 France Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Injectable Anticoagulants Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Injectable Anticoagulants Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Injectable Anticoagulants Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Injectable Anticoagulants Market Size by Region
    • 8.3.1 Asia-Pacific Injectable Anticoagulants Consumption Value by Region (2019-2030)
    • 8.3.2 China Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 8.3.5 India Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Injectable Anticoagulants Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Injectable Anticoagulants Consumption Value by Type (2019-2030)
  • 9.2 South America Injectable Anticoagulants Consumption Value by Application (2019-2030)
  • 9.3 South America Injectable Anticoagulants Market Size by Country
    • 9.3.1 South America Injectable Anticoagulants Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Injectable Anticoagulants Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Injectable Anticoagulants Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Injectable Anticoagulants Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Injectable Anticoagulants Market Size by Country
    • 10.3.1 Middle East & Africa Injectable Anticoagulants Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Injectable Anticoagulants Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Injectable Anticoagulants Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Injectable Anticoagulants Market Drivers
  • 11.2 Injectable Anticoagulants Market Restraints
  • 11.3 Injectable Anticoagulants Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Injectable Anticoagulants Industry Chain
  • 12.2 Injectable Anticoagulants Upstream Analysis
  • 12.3 Injectable Anticoagulants Midstream Analysis
  • 12.4 Injectable Anticoagulants Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.
    According to our (Global Info Research) latest study, the global Injectable Anticoagulants market size was valued at US$ 7351 million in 2023 and is forecast to a readjusted size of USD 10630 million by 2030 with a CAGR of 5.5% during review period.
    Global key injectable anticoagulants brands include Sanofi, Genentech(Roche) and Boehringer Ingelheim etc. The top 3 companies hold a share about 55%. Europe is the largest market with a share about 34%, followed by North America and Asia-Pacific.
    In terms of product, LMWH is the largest segment with a share about 50%. And in terms of applications, the largest application is VTE with a share about 76%.
    This report is a detailed and comprehensive analysis for global Injectable Anticoagulants market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Injectable Anticoagulants market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Injectable Anticoagulants market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Injectable Anticoagulants market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Injectable Anticoagulants market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Injectable Anticoagulants
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Injectable Anticoagulants market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Genentech (Roche), Boehringer Ingelheim, Aspen, Pfizer, Hepalink, King-friend, CSBIO, Amphastar Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Injectable Anticoagulants market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Injectable Anticoagulants market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    LMWH
    Unfractionated Heparin
    Fibrinolytics
    Others
    Market segment by Application
    VTE
    ACS/MI
    AF
    Others
    Market segment by players, this report covers
    Sanofi
    Genentech (Roche)
    Boehringer Ingelheim
    Aspen
    Pfizer
    Hepalink
    King-friend
    CSBIO
    Amphastar Pharmaceuticals
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Injectable Anticoagulants product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Injectable Anticoagulants, with revenue, gross margin, and global market share of Injectable Anticoagulants from 2019 to 2024.
    Chapter 3, the Injectable Anticoagulants competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Injectable Anticoagulants market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Injectable Anticoagulants.
    Chapter 13, to describe Injectable Anticoagulants research findings and conclusion.

    Buy now